November 20th 2024, 10:00pm
By Gina Mauro
PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels were linked to worse outcomes.
November 20th 2024, 8:00pm
By Ashley Chan
Patients with relapsed or refractory MDS may experience improved overall survival with DLI, depending on certain prognostic factors.
November 20th 2024, 6:00pm
By Mary Sansone
During the holiday season, overwhelming feelings are OK to have, whether you are a patient with cancer or a caregiver.
November 20th 2024, 4:00pm
By Ryan Scott
The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia.
November 20th 2024, 2:00pm
By Alex Biese
CURE® spoke with a physical therapist specializing in oncology to find out more about this condition some patients with cancer are at risk for.
November 19th 2024, 10:00pm
By Spencer Feldman
New treatments for acute lymphoblastic leukemia may lead to fewer side effects than chemotherapy, as they target cancer cells more precisely, an expert said.
November 19th 2024, 8:00pm
Researchers have found an overall survival benefit and manageable safety profile with Venclexta for patients with AML and MDS.
November 19th 2024, 6:00pm
By Kelly Irvin
Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.
November 19th 2024, 4:00pm
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients with cancer to enroll.
November 19th 2024, 2:00pm
Treatment with Columvi showed a manageable safety profile in heavily pre-treated patients with relapsed or refractory mantle cell lymphoma.
November 18th 2024, 10:00pm
A trial evaluating the tamibarotene-Vidaza combination in certain patients with newly diagnosed high-risk MDS will be discontinued.
November 18th 2024, 8:00pm
RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more research is necessary.
November 18th 2024, 6:00pm
By Jessica Bolz
As a four-time cancer survivor, I can tell you that survivorship means many things to each survivor.
November 18th 2024, 5:29pm
By Joseph F. Renzulli MD, FACS
Panelists discuss the key takeaways from their experiences in treating advanced prostate cancer, emphasizing valuable lessons learned throughout the treatment journey that can guide future patient care and support.
Panelists discuss key advice for patients and caregivers navigating advanced prostate cancer, highlighting essential insights for those newly diagnosed and sharing valuable guidance received from health care professionals and advocates during their journeys.
Why Clinical Trials Don’t Have to Be Patients’ ‘Last Line of Defense’
November is National Family Caregivers Month!
November 2024 - COA Patient Advocacy Network News Bulletin
CR&T Honors Dr Richard T. Silver with its Humanitarian Award